Cas:42872-83-3 2-Bromo-5-methylbenzonitrile manufacturer & supplier

We serve Chemical Name:2-Bromo-5-methylbenzonitrile CAS:42872-83-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Bromo-5-methylbenzonitrile

Chemical Name:2-Bromo-5-methylbenzonitrile
CAS.NO:42872-83-3
Synonyms:2-Brom-5-methylbenzonitril;2-Brom-5-methyl-benzonitril;2-bromo-5-methylbenzylnitrile;4-Brom-3-cyanotoluol;6-Bromo-m-tolunitrile;2-Bromo-5-methylbenzonitrile;Benzonitrile, 2-bromo-5-methyl-;4-Bromo-3-cyanotoluene;2-bromo-5-methyl-benzonitrile
Molecular Formula:C8H6BrN
Molecular Weight:196.044
HS Code:2926909090

Physical and Chemical Properties:
Melting point:61-65ºC
Boiling point:290.2±28.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.591
PSA:23.79000
Exact Mass:194.968353
LogP:2.69

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 2-Brom-5-methylbenzonitril chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo-5-methyl-benzonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Brom-5-methylbenzonitril Use and application,2-Brom-5-methyl-benzonitril technical grade,usp/ep/jp grade.


Related News: “It’s truly an important scientific issue and important public health issue and FDA is actively exploring all regulatory options for providing access to additional doses of authorized vaccines in situations where data suggests the benefits would outweigh the risks,” Fink said. (1R,3R,4R,1’S)-3-(imidazol-4-yl)-4-(1′-Acetamido-3′-Methyl)butyl-cyclopentane-1-carboxylic acid manufacturers As Natural Capsules did not have access to this manufacturing technology, its R&D centre, which is DSIR approved, had started working on the same since 2018, and has now successfully developed the process including fermentation and chemical synthesis steps, Sunil Mundra, managing director, Natural Capsules told Pharmabiz. 1,1′-(4,4′-(3,4-diphenylthiophene-2,5-diyl)bis(4,1-phenylene))diethanone suppliers AstraZeneca’s application for anifrolumab in SLE is under review by regulatory authorities in the US, EU and Japan, with decisions anticipated in the second half of 2021. Anifrolumab is not currently approved in any country. 2-(2,5,8,11,14-Pentaoxa-bicyclo[13.3.1]nonadeca-1(18),15(19),16-trien-17-ylmethyl)-isoindole-1,3-dione vendor & factory.